X0306 4 2013-01-14 0 0001415336 Zeltiq Aesthetics Inc ZLTQ 0001528831 Tatsutani Kristine N 4698 WILLOW ROAD SUITE 100 PLEASANTON CA 94588 0 1 0 0 CSO, SVP of Reg., Clinic & QA Common Stock 2013-01-14 4 M 0 4008 2.83 A 36700 D Common Stock 2013-01-14 4 S 0 4008 4.8609 D 32692 D Common Stock 2013-01-15 4 M 0 7343 2.83 A 40035 D Common Stock 2013-01-15 4 S 0 7343 4.6787 D 32692 D Stock Option (right to buy) 2.83 2013-01-14 4 M 0 4008 0.00 D 2021-05-17 Common Stock 4008 113688 D Stock Option (right to buy) 2.83 2013-01-15 4 M 0 7343 0.00 D 2021-05-17 Common Stock 7343 106345 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2012. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $4.92 inclusive. The reporting person undertakes to provide to ZELTIQ Aesthetics, Inc., any security holder of ZELTIQ Aesthetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.87 inclusive. The reporting person undertakes to provide to ZELTIQ Aesthetics, Inc., any security holder of ZELTIQ Aesthetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. 25% of the granted 117,696 shares became exercisable on 5/18/12. The remaining shares vest in a series of 36 equal monthly installments, provided the Reporting Person continues to provide service to ZELTIQ Aesthetics, Inc. s/Sergio Garcia, attorney-in-fact 2013-01-16